GSK Announces Leadership Change as CEO Emma Walmsley Steps Down
GSK is undergoing a leadership transition as CEO Emma Walmsley steps down after nearly nine years. Luke Miels, the current chief commercial officer, will succeed her starting January 1. This change is seen as a pivotal moment for the company, which aims to revitalize its product pipeline and adapt to the competitive pharmaceutical landscape. Stakeholders are hopeful for new strategies and innovations under Miels' leadership.
GSK Announces Leadership Change as CEO Emma Walmsley Steps Down
GSK is undergoing a leadership transition as CEO Emma Walmsley steps down after nearly nine years. Luke Miels, the current chief commercial officer, will succeed her starting January 1. This change is seen as a pivotal moment for the company, which aims to revitalize its product pipeline and adapt to the competitive pharmaceutical landscape. Stakeholders are hopeful for new strategies and innovations under Miels' leadership.
Why World Pulse Now
Global Coverage
All major sources, one page
Emotional Lens
Feel the mood behind headlines
Trending Stories
Know what’s trending, globally
Read Less, Know More
Get summaries. Save time
Multi-Language
Switch languages to read your way
Save for Later
Your stories, stored for later
Live Stats
Our system has analyzed 4,571 articles worldwide
~190 per hour
499 trending stories shaping headlines
From breaking news to viral moments
Monitoring 198 trusted sources
Major outlets & specialized publications
Latest update an hour ago
Always fresh